Tami L. Bair, BS

Original Contribution

Real-World Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors
during Percutaneous Coronary Intervention

08/01/2008

Jeffrey L. Anderson , MD;

Joseph Brent Muhlestein , MD, FAHA, FACC;

Peter J. Casterella , MD;

James R. Revenaugh , MD;

James L. Burke , MD;

Robert R. Pearson , BS;

Tami L. Bair , BS;

Heidi T. May , MSPH, PhD;

Benjamin Horne , PhD, MPH;

Percutaneous coronary intervention (PCI) is commonly employed in the management of patients with coronary artery disease (CAD), but the optimal adjunctive pharmacologic strategy for patients undergoing PCI is a frequently debated issue,...

Percutaneous coronary...

08/01/2008

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

November 8

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Tami L. Bair, BS

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products